Review demonstrates reduced reliance on lung transplantation in chronic thromboembolic pulmonary hypertension, highlighting the impact of modern therapeutic advancements.
Therapeutic advances in chronic thromboembolic pulmonary hypertension (CTEPH) over the last 10 years have improved patient prognosis. As a result, the role of lung transplantation (LTx) for this indication has been greatly reduced. In this review article, we describe the evolution of treatments for CTEPH, the place that remains for lung transplantation, and the particularities of lung transplantation for this indication.
No takes yet. Share an insight, caveat, or question.
Godinas et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: